NSAIDs, Myocardial infarction, rebound effect and similitude

Homeopathy

Volumn 96, Issue 1, 2007, Pages 67-68

  Teixeira, Marcus Zulian ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; INDOMETACIN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; THROMBIN;

CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; DOSE RESPONSE; DRUG WITHDRAWAL; HEART INFARCTION; HOMEOPATHY; HUMAN; LETTER; PARADOXICAL DRUG REACTION; REBOUND; SIDE EFFECT; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOGENESIS; TREATMENT DURATION;

ANTIDEPRESSIVE AGENTS; ASPIRIN; BRONCHODILATOR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HOMEOPATHY; HUMANS; IATROGENIC DISEASE; LACTONES; MATERIA MEDICA; RESEARCH DESIGN; SULFONES;

EID: 33846148713     PISSN: 14754916     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.homp.2006.11.009     Document Type: Letter

References (14)

1. Teixeira M.Z. Evidence of the principle of similitude in modern fatal iatrogenic events. Homeopathy 95 4 (2006) 229-236
2. Fischer L.M., Schlienger R.G., Matter C.M., Jick H., and Meier C.R. Discontinuation of nonsteroidal anti-inflammatory drugs is associated with an increased risk of acute myocardial infarction. Arch Intern Med 164 (2004) 2472-2476
3. Kearney P.M., Baigent C., Godwin J., Halls H., Emberson J.R., and Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 332 7553 (2006) 1302-1308
4. Andrioli G., Lussignoli S., Ortolani R., Minuz P., Vella F., and Bellavite P. Dual effects of diclofenac on human platelet adhesion in vitro. Blood Coagul Fibrinolysis 7 2 (1996) 153-156
5. Andrioli G., Lussignoli S., Gaino S., Benoni G., and Bellavite P. Study on paradoxical effects of NSAIDs on platelet activation. Inflammation 21 5 (1997) 519-530
6. McGettingan P., and Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 296 13 (2006) 1633-1644
7. Helin-Salmivaara A., Virtanen A., Vesalainen R., et al. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland. Eur Heart J 27 14 (2006) 1657-1663
8. Dayneka N.L., Garg V., and Jusko W.J. Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 21 4 (1993) 457-478
9. Krzyzanski W., and Jusko W.J. Mathematical formalism for the properties of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 25 1 (1997) 107-123
10. Sharma A., Ebling W.F., and Jusko W.J. Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena. J Pharm Sci 87 12 (1998) 1577-1584
11. Hazra A., Krzyzanski W., and Jusko W.J. Mathematical assessment of properties of precursor-dependent indirect pharmacodynamic response models. J Pharmacokinet Pharmacodyn 33 6 (2006) 683-717
12. Serebruany V.L., Malinin A.I., and Bhatt D.L. Paradoxical rebound platelet activation after painkillers cessation: missing risk for vascular events?. Am J Med 119 8 (2006) 707.e11-6
13. Goldenberg N.A., Jacobson L., and Manco-Johnson M.J. Brief communication: duration of platelet dysfunction after a 7-day course of Ibuprofen. Ann Intern Med 142 7 (2005) 506-509
14. Collet J.P., Montalescot G., Blanchet B., et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 110 16 (2004) 2361-2367